These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24501745)

  • 41. Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.
    Prado MJ; de Castro SM; Kopacek C; de Mello MP; Rispoli T; Grandi T; da Silva CMD; Rossetti MLR
    Mol Diagn Ther; 2017 Dec; 21(6):663-675. PubMed ID: 28819757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CYP21A2 and CYP11B1 gene analyses in a virilized newborn female with congenital adrenal hyperplasia.
    Llorente Martín E; Dabad Moreno MJ; Ezquieta Zubicaray B
    Med Clin (Barc); 2023 Nov; 161(10):448-449. PubMed ID: 37598052
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of TaqI digestion may lead to incorrect molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lee HH; de Wijs IJ; Sistermans EA
    Mol Genet Metab; 2000 Aug; 70(4):322-4. PubMed ID: 10993720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-classical congenital adrenal hyperplasia.
    Dacou-Voutetakis C; Dracopoulou M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():195-7. PubMed ID: 16641859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
    Liao XY; Zhang YF; Gu XF
    Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comment on congenital adrenal hyperplasia without demonstrable genetic mutations.
    White PC
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2976-7. PubMed ID: 10443708
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.
    Tajima T; Fujieda K; Nakayama K; Fujii-Kuriyama Y
    J Clin Invest; 1993 Nov; 92(5):2182-90. PubMed ID: 8227333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Linkage analysis between HLA and GLOI with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Turowska-Heydel D; Sanak M; Turowska B; Pietrzyk JJ; Turowski G
    Pediatr Pol; 1995 Feb; 70(2):121-5. PubMed ID: 7603794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].
    Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B
    Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262
    [No Abstract]   [Full Text] [Related]  

  • 51. Congenital adrenal hyperplasia in adolescents: diagnosis and management.
    Lin-Su K; Nimkarn S; New MI
    Ann N Y Acad Sci; 2008; 1135():95-8. PubMed ID: 18574213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene symbol: CYP21A2. Disease: steroid 21-hydroxylase deficiency.
    Tardy V
    Hum Genet; 2006 Apr; 119(3):363. PubMed ID: 17230656
    [No Abstract]   [Full Text] [Related]  

  • 53. [Genetic counseling and prenatal diagnosis of adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Couillin P
    Presse Med; 1984 Apr; 13(17):1087-90. PubMed ID: 6232534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How can molecular biology contribute to the management of congenital adrenal hyperplasia?
    Ritzén EM; Lajic S; Wedell A
    Horm Res; 2000; 53 Suppl 1():34-7. PubMed ID: 10895040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of pathogenic mutations in 21-hydroxylase gene of Pakistani patients with congenital adrenal hyperplasia and their family members--a preliminary report.
    Khan AH; Nasir MI; Moatter T
    J Pak Med Assoc; 2002 Jul; 52(7):287-91. PubMed ID: 12481658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification.
    Theodoropoulou M; Barta C; Szoke M; Guttman A; Staub M; Niederland T; Sólyom J; Fekete G; Sasvari-Szekely M
    Fetal Diagn Ther; 2001; 16(4):237-40. PubMed ID: 11399887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Congenital adrenal hyperplasia.
    Wedell A
    Clin Biochem; 2011 May; 44(7):505-506. PubMed ID: 22036349
    [No Abstract]   [Full Text] [Related]  

  • 58. Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Grötzinger J; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 2005 Jan; 90(1):445-54. PubMed ID: 15483094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A molecular method of diagnosis of congenital adrenal hyperplasia].
    Israel S; Brautbar C
    Harefuah; 2000 Dec; 139(11-12):429-33, 494. PubMed ID: 11341187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New concepts in virilizing adrenal hyperplasia caused by 21-hydroxylase block].
    Cortínez A; Beas F; Devoto L; Henríquez C
    Rev Chil Pediatr; 1985; 56(3):192-8. PubMed ID: 3879364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.